Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point of View

@inproceedings{Wirsching2017UpdateOC,
  title={Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point
of View},
  author={Kornelia E. C. Wirsching and Thomas S. Kuehnel},
  booktitle={Clinical and experimental otorhinolaryngology},
  year={2017}
}
OBJECTIVES Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of vascular malformations with an absence of capillaries between arteries and veins. One major manifestation site is the nasal mucous membrane where recurrent nosebleeds occur. Our clinical strategy to treat patients with HHT has the aim to reduce nasal bleeding long-term with minimal local and general side effects. METHODS We describe staged diagnosis and therapy including individual medical treatments of… CONTINUE READING
5 Citations
22 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Similar Papers

Loading similar papers…